JFG
RAPT

Jefferies Financial Group’s RAPT Therapeutics RAPT Stock Holding History

Jefferies Financial Group’s Portfolio RAPT Stock Details RAPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,306
Closed -$21K – 1802
2024
Q3 		$21K Buy
+1,306
New +$26.4K ﹤0.01% 1372
2024
Q2 		– Sell
-1,649
Closed -$118K – 1797
2024
Q1 		$118K Hold
1,649
– – ﹤0.01% 1415
2023
Q4 		$328K Sell
1,649
-4,443
-73% -$550K ﹤0.01% 1345
2023
Q3 		$810K Hold
6,092
– – 0.01% 898
2023
Q2 		$911K Hold
6,092
– – 0.01% 956
2023
Q1 		$894K Buy
+6,092
New +$1.23M 0.01% 933

Other funds holding RAPT

MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jefferies Financial Group's RAPT Position: Q4 2024 in Review

Jefferies Financial Group sold out of RAPT Therapeutics (RAPT) in Q4 2024, closing a stake of 1,306 shares — an estimated $21K sold.

Jefferies Financial Group first reported a position in RAPT in Q1 2023 and held it in 6 quarters. The position peaked at $911K in Q2 2023. 91 funds tracked by Wall St. Rank hold RAPT as of Q4 2024.

  • Jefferies Financial Group reported no remaining RAPT Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Jefferies Financial Group sold 1,306 RAPT Therapeutics shares in Q4 2024, an estimated $21K.
  • Jefferies Financial Group first reported a position in RAPT Therapeutics in Q1 2023 and held it in 6 quarters.
  • Jefferies Financial Group's RAPT Therapeutics position peaked at $911K in Q2 2023.
  • 91 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q4 2024.

Based on Jefferies Financial Group's 13F filing for Q4 2024, filed 14 Feb 2025.